Phencyclidine and phenylcyclohexene disposition after smoking phencyclidine
- 1 May 1982
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 31 (5) , 635-641
- https://doi.org/10.1038/clpt.1982.88
Abstract
Five men who smoked parsley cigarettes containing 100 .mu.g of [3H]phencyclidine hydrochloride, (PCP .cntdot. HCl) [a drug of abuse] inhaled 69 .+-. 5(SEM [SE of the mean]) % of the total radioactivity in the cigarette. Both PCP and its pyrolysis product, 1-phenylcyclohexene (PC), were found and measured in plasma. Calculations based on the assumption that the ratio of these 2 products was the same as in simulated smoking studies and based on either area under the curve or urinary excretion of PCP indicated that most of the PCP in smoke was absorbed. Mean half-life (t1/2) of PCP (24 .+-. 7 h, harmonic mean 18 h) and ratios of metabolites in plasma and urine were close to those previously reported after i.v. and oral doses. A 2nd peak in PCP plasma concentrations was observed possibly due to slow efflux from the lungs. PC plasma concentrations (maximum 0.35 .+-. 0.06 pmol/ml) were lower than those of PCP (maximum 0.62 .+-. 0.09 pmol/ml) and its mean t1/2 (14 .+-. 3 h, harmonic mean 12 h) was shorter than that of PCP. Only traces of PC were found in urine. Only small amounts of metabolites from PC were found nonconjugated in plasma (to .apprx. 0.1 pmol/ml) or urine (< 2% of radioactivity), but larger quantities were found as enzyme-hydrolyzable conjugates in urine (6% of radioactivity). Conjugates were also found in plasma (to .apprx. 0.12 pmol/ml).This publication has 1 reference indexed in Scilit:
- Phencyclidine disposition after intravenous and oral dosesClinical Pharmacology & Therapeutics, 1982